[Abstract Only] Randomized trial: Upadacitinib vs. Abatacept in rheumatoid arthritis
16 Oct, 2020 | 09:28h | UTCTrial of Upadacitinib or Abatacept in Rheumatoid Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Rheumatoid Arthritis: When DMARDs Fail, Can JAK Inhibitors Step In? – Physician’s Weekly